JPMorgan To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

  • Morgan Stanley raised JPMorgan Chase & Co. (NYSE:JPM) price target from $187 to $191. Morgan Stanley analyst Betsy Graseck maintained an Overweight rating on the stock. JPMorgan shares rose 1.5% to close at $148.00 on Friday. See how other analysts view this stock.
  • Morgan Stanley slashed Apple Inc. (NASDAQ:AAPL) price target from $215 to $210. Morgan Stanley analyst Erik Woodring maintained an Overweight rating. Apple shares fell 0.5% to $177.93 in pre-market trading. See how other analysts view this stock.
  • Keybanc raised the price target for Lennox International Inc. (NYSE:LII) from $400 to $415. Keybanc analyst Jeffrey Hammond maintained an Overweight rating. Lennox International shares fell 3.9% to close at $369.74 on Friday. See how other analysts view this stock.
  • Rosenblatt increased the price target for Microsoft Corporation (NASDAQ:MSFT) from $360 to $370. Rosenblatt analyst Blair Abernethy maintained a Buy rating. Microsoft shares fell 1% to close at $327.73 on Friday. See how other analysts view this stock.
  • Susquehanna increased Trinity Industries, Inc. (NYSE:TRN) price target from $29 to $32. Susquehanna analyst Bascome Majors upgraded the stock from Neutral to Positive. Trinity Industries shares rose 3% to $22.57 in pre-market trading. See how other analysts view this stock.
  • Wells Fargo cut Pfizer Inc. (NYSE:PFE) price target from $39 to $35. Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating. Pfizer shares fell 2.5% to close at $32.11 on Friday. See how other analysts view this stock.
  • Stifel cut Colgate-Palmolive Company (NYSE:CL) price target from $85 to $81. Stifel analyst Mark Astrachan upgraded the stock from Hold to Buy. Colgate-Palmolive shares rose 1.3% to $71.87 in pre-market trading. See how other analysts view this stock.
  • HC Wainwright & Co. slashed the price target for Plug Power Inc. (NASDAQ:PLUG) from $78 to $27. HC Wainwright & Co. analyst Amit Dayal maintained a Buy rating. Plug Power shares rose 0.8% to $7.40 in pre-market trading. See how other analysts view this stock.
  • Morgan Stanley raised Check Point Software Technologies Ltd. (NASDAQ:CHKP) price target from $118 to $144. Morgan Stanley analyst Hamza Fodderwala upgraded the stock from Underweight to Equal-Weight. Check Point shares gained 1.2% to $135.95 in pre-market trading. See how other analysts view this stock.
  • Goldman Sachs slashed KB Home (NYSE:KBH) price target from $54 to $48. Goldman Sachs analyst Susan Maklari downgraded the stock from Buy to Neutral. KB Home shares fell 2.4% to $42.82 in pre-market trading. See how other analysts view this stock.

 

Check This Out: Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying

Total
0
Shares
Related Posts
Read More

Aurinia Pharmaceuticals Announced Departure of Executive Vice President, Research and Chief Medical Officer

On October 17, 2022, Aurinia Pharmaceuticals Inc. and Robert Huizinga, PhD RN, CNeph(C), our Executive Vice President, Research and Neil Solomons, M.D., our ChiefMedical Officer, mutually agreed that Dr. Huizinga and Dr. Solomons would cease their employment with Aurinia, each effective October 31, 2022.We expect to enter into separation agreements with Dr. Huizinga and Dr.

AUPH